Andreas Janzer
6Patents
2h-index
28Co-inventors
43Inventor score
Filing activity: Aug 29, 2016 → Aug 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10815215B2 | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH | Emerging Cross-Sectional Technologies | 3 | Active |
| US11130745B2 | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH | Emerging Cross-Sectional Technologies | 2 | Active |
| US10968216B2 | 4,5-annulated 1,2,4-triazolones | Emerging Cross-Sectional Technologies | 2 | Active |
| US11787797B2 | 4,5-annulated 1,2,4-triazolones | Emerging Cross-Sectional Technologies | 0 | Active |
| US11713304B2 | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH | Emerging Cross-Sectional Technologies | 0 | Active |
| US11096934B2 | Compounds and methods useful for treating or preventing hematological cancers | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.